Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
History
TV & Film
Sports
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/55/a4/83/55a483d3-a782-a437-d664-30d4d728a35a/mza_8023322408084933977.jpg/600x600bb.jpg
Your Checkup: Patient Education Health Podcast
Ed Delesky, MD and Nicole Aruffo, RN
92 episodes
1 day ago
Send us a message with this link, we would love to hear from you. Standard message rates may apply. Oral Wegovy is officially FDA approved — but what does that actually mean for patients? In this episode of Your Checkup, we break down the December 2025 approval of oral semaglutide 25 mg for chronic weight management, who qualifies, how it works, and how effective it really is. We review the clinical trial data behind the approval, including expected weight loss, common side effects, and...
Show more...
Medicine
Education,
Self-Improvement,
Health & Fitness
RSS
All content for Your Checkup: Patient Education Health Podcast is the property of Ed Delesky, MD and Nicole Aruffo, RN and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Send us a message with this link, we would love to hear from you. Standard message rates may apply. Oral Wegovy is officially FDA approved — but what does that actually mean for patients? In this episode of Your Checkup, we break down the December 2025 approval of oral semaglutide 25 mg for chronic weight management, who qualifies, how it works, and how effective it really is. We review the clinical trial data behind the approval, including expected weight loss, common side effects, and...
Show more...
Medicine
Education,
Self-Improvement,
Health & Fitness
https://storage.buzzsprout.com/954k0xnchwkx7n8ufg90dq5oqk2i?.jpg
87: GLP-1 Price Cuts: Will It Improve Access?
Your Checkup: Patient Education Health Podcast
29 minutes
1 month ago
87: GLP-1 Price Cuts: Will It Improve Access?
Send us a message with this link, we would love to hear from you. Standard message rates may apply. We unpack new GLP-1 pricing, coverage hurdles, and whether cash-pay programs make these meds more reachable for diabetes, obesity, and sleep apnea care. Along the way we share candid pros and cons of injections, tease future oral options, and weigh real tradeoffs. • current cash-pay pricing from major manufacturers • differences between Wegovy, Ozempic, and Zepbound • tighter insurance coverag...
Your Checkup: Patient Education Health Podcast
Send us a message with this link, we would love to hear from you. Standard message rates may apply. Oral Wegovy is officially FDA approved — but what does that actually mean for patients? In this episode of Your Checkup, we break down the December 2025 approval of oral semaglutide 25 mg for chronic weight management, who qualifies, how it works, and how effective it really is. We review the clinical trial data behind the approval, including expected weight loss, common side effects, and...